scholarly article | Q13442814 |
P356 | DOI | 10.1111/AOR.12022 |
P698 | PubMed publication ID | 23551257 |
P50 | author | Paolo De Coppi | Q3893966 |
Alexander M Seifalian | Q57972310 | ||
P2093 | author name string | Achala de Mel | |
Giorgio Cittadella | |||
Ryan Dee | |||
P2860 | cites work | Graft type for femoro-popliteal bypass surgery | Q24235263 |
Smooth muscle and other cell sources for human blood vessel engineering | Q26862581 | ||
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces | Q28168554 | ||
First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo | Q30980855 | ||
Electrospinning-aligned and random polydioxanone-polycaprolactone-silk fibroin-blended scaffolds: geometry for a vascular matrix. | Q33509481 | ||
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling | Q33537670 | ||
Cellular plasticity of inflammatory myeloid cells in the peritoneal foreign body response | Q33556377 | ||
Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. | Q33921156 | ||
Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. | Q34236181 | ||
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Q34236195 | ||
Human arteries engineered in vitro | Q34236694 | ||
Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. | Q34240471 | ||
Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review | Q34843553 | ||
Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. | Q34876387 | ||
Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel | Q35105356 | ||
A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts | Q35609601 | ||
Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI | Q35609635 | ||
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts | Q35906795 | ||
Tissue engineering of blood vessels | Q36405174 | ||
Addressing thrombogenicity in vascular graft construction | Q36641036 | ||
Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model | Q36645337 | ||
Tetralogy of fallot: yesterday and today | Q37678967 | ||
Tissue engineering on matrix: future of autologous tissue replacement | Q37833522 | ||
Vascularizing the heart | Q37833832 | ||
Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth | Q37875978 | ||
Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
The evolution of vascular tissue engineering and current state of the art. | Q37945454 | ||
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? | Q37969874 | ||
Creation of viable pulmonary artery autografts through tissue engineering | Q38552626 | ||
Compliant electrospun silk fibroin tubes for small vessel bypass grafting. | Q42021035 | ||
Human tissue-engineered blood vessels for adult arterial revascularization | Q42382267 | ||
Development of an operator-independent method for seeding tissue-engineered vascular grafts | Q42775727 | ||
Late-term results of tissue-engineered vascular grafts in humans | Q43182712 | ||
Outcome of 200 patients after an extracardiac Fontan procedure | Q43553981 | ||
Aortoiliac reconstruction in infants and toddlers: replacement with decellularized branched pulmonary artery allograft | Q43812818 | ||
Successful application of tissue engineered vascular autografts: clinical experience | Q44181125 | ||
In vivo study of a model tissue-engineered small-diameter vascular bypass graft | Q44337285 | ||
Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo | Q44971267 | ||
Use of a "composite" vascular access graft in a young child on hemodialysis. | Q46011768 | ||
Decellularized Native and Engineered Arterial Scaffolds for Transplantation | Q46045991 | ||
The tissue-engineered vascular graft using bone marrow without culture | Q46193787 | ||
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells | Q46533885 | ||
Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts | Q46698962 | ||
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association | Q48186007 | ||
Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. | Q49097750 | ||
Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. | Q50509675 | ||
Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. | Q50575954 | ||
Tissue-engineered blood vessel for adult arterial revascularization. | Q50897506 | ||
Functional tissue-engineered blood vessels from bone marrow progenitor cells. | Q51000514 | ||
Arteriovenous graft infection: a comparison of thigh and upper extremity grafts. | Q51029206 | ||
Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. | Q51363869 | ||
P433 | issue | 5 | |
P304 | page(s) | 423-434 | |
P577 | publication date | 2013-04-04 | |
P1433 | published in | Artificial Organs | Q15751140 |
P1476 | title | Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts | |
P478 | volume | 37 |
Q52962221 | A potential platform for developing 3D tubular scaffolds for paediatric organ development. |
Q38194192 | Artificial Organs 2013: a year in review |
Q38506920 | Cells and stimuli in small-caliber blood vessel tissue engineering |
Q51306340 | Contact-free monitoring of vessel graft stiffness - proof of concept as a tool for vascular tissue engineering. |
Q38738903 | Historical Perspective and Future Direction of Blood Vessel Developments |
Q36258300 | In vitro degradation and cell attachment studies of a new electrospun polymeric tubular graft |
Q34563078 | Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts |
Q38192824 | Regenerative implants for cardiovascular tissue engineering |
Search more.